US Patent Issued to ELI LILLY and Co. on Feb. 10 for "Crystalline forms of a farnesoid X receptor agonist" (California Inventors)

ALEXANDRIA, Va., Feb. 11 -- United States Patent no. 12,545,660, issued on Feb. 10, was assigned to ELI LILLY AND COMPANY (Indianapolis).

"Crystalline forms of a farnesoid X receptor agonist" was invented by Nicholas D. Smith (San Diego) and Robert Mansfield (San Diego).

According to the abstract* released by the U.S. Patent & Trademark Office: "Described herein is the farnesoid X receptor agonist, 4-((4-(1-(tert-butyl)-1H-pyrazol-4-yl)pyridin-2-yl)((4-(4-methoxy-3-methylphenyl)bicyclo[2.2.2]octan-1-yl)methyl)carbamoyl)cyclohexyl 3-hydroxyazetidine-trans-1-carboxylate, including crystalline forms and pharmaceutically acceptable salts, solvates, and formulations thereof."

The patent was filed on March 17, 2021, under Application No. 17/90...